Open Access

Interleukin‑6 released by oral lichen planus myofibroblasts promotes angiogenesis

  • Authors:
    • Xiao-Heng Xu
    • Yang Liu
    • Lu Feng
    • Yin-Shen Yang
    • Shu-Guang Liu
    • Wei Guo
    • Hui-Xi Zhou
    • Zhi-Qiang Li
    • Lin Zhang
    • Wen-Xia Meng
  • View Affiliations

  • Published online on: January 27, 2021     https://doi.org/10.3892/etm.2021.9722
  • Article Number: 291
  • Copyright: © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Oral lichen planus (OLP), defined as a potential for malignant transformation, is a chronic inflammatory disease in which abnormal angiogenesis serves a role in the malignant changes of the disease. OLP‑associated fibroblasts (OLP‑MFs), derived from the stroma of OLP tissues, are characterized by the presence of myofibroblasts and contribute to the secretion of pro‑inflammatory cytokines, which may be involved in the molecular pathogenesis of OLP. However, the associated mechanisms of angiogenesis in OLP remain unknown. The present study aimed to verify the expression of intercellular adhesion molecular 1, vascular cell adhesion molecule 1, VEGF and CD34 in OLP, and to investigate whether IL‑6 secreted by OLP‑MFs promoted OLP angiogenesis and the effect of its corresponding antibody inhibition. The results of the experiments demonstrated that inflammation was present and OLP upregulated the secretion of IL‑6 by OLP stromal fibroblasts, thereby enhancing OLP angiogenesis. Anti‑IL‑6 receptor antibody inhibited OLP‑stroma IL‑6 signaling and suppressed OLP angiogenesis. The antibody inhibited the inflammatory response by inhibiting the secretion of inflammatory factors, including IL‑6, to suppress angiogenesis and reduce disease progression, thus indicating that this could be a potential target to develop a treatment for OLP.
View Figures
View References

Related Articles

Journal Cover

April-2021
Volume 21 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

The Cancer Story
Copy and paste a formatted citation
x
Spandidos Publications style
Xu X, Liu Y, Feng L, Yang Y, Liu S, Guo W, Zhou H, Li Z, Zhang L, Meng W, Meng W, et al: Interleukin‑6 released by oral lichen planus myofibroblasts promotes angiogenesis. Exp Ther Med 21: 291, 2021
APA
Xu, X., Liu, Y., Feng, L., Yang, Y., Liu, S., Guo, W. ... Meng, W. (2021). Interleukin‑6 released by oral lichen planus myofibroblasts promotes angiogenesis. Experimental and Therapeutic Medicine, 21, 291. https://doi.org/10.3892/etm.2021.9722
MLA
Xu, X., Liu, Y., Feng, L., Yang, Y., Liu, S., Guo, W., Zhou, H., Li, Z., Zhang, L., Meng, W."Interleukin‑6 released by oral lichen planus myofibroblasts promotes angiogenesis". Experimental and Therapeutic Medicine 21.4 (2021): 291.
Chicago
Xu, X., Liu, Y., Feng, L., Yang, Y., Liu, S., Guo, W., Zhou, H., Li, Z., Zhang, L., Meng, W."Interleukin‑6 released by oral lichen planus myofibroblasts promotes angiogenesis". Experimental and Therapeutic Medicine 21, no. 4 (2021): 291. https://doi.org/10.3892/etm.2021.9722